Organization: Avid Radiopharmaceuticals Inc

MDS Nordion teams with Avid Radiopharmaceuticals

MDS Nordion, Ottawa, is collaborating with Avid Radiopharmaceuticals Inc, Philadelphia PA, to conduct clinical trials for Avid’s radiopharmaceuticals designed to diagnose and monitor Alzheimer’s disease. MDS Nordion will radiolabel Avid compounds for use in proof-of-concept clinical trials for Avid’s single proton emission computed tomography (SPECT) molecular imaging technology….